Kala Bio KALA
NASDAQ KALA
$0.17 +0.01 (+8.99%)
As of: Nov 9, 2026 · 12:01 PM EST

Kala Bio (KALA) Gross Profit (2019 - 2022)

Updated

Kala Bio (KALA) reported Gross Profit of $1.33 million for FY2022, down 81.4% from $7.14 million in FY2021.

Analysis

Kala Bio (KALA) Gross Profit (2019 - 2022) Analysis & Trends

Dating back to FY2019, Kala Bio's Gross Profit record includes 4 years.

  • Gross Profit has a three-year compound annual growth rate of -31.1% (FY2019 to FY2022).
  • According to Business Quant data, Gross Profit came in at $7.14 million in FY2021 (+124.0%), $3.19 million in FY2020 (-21.6%) and $4.07 million in FY2019.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,246.80 Bn 1,220.42 Bn 20.46 Bn
2 Johnson & Johnson 674.35 Bn 594.21 Bn 17.30 Bn
3 AbbVie 517.12 Bn 485.13 Bn 13.12 Bn
4 Merck 364.12 Bn 327.06 Bn 13.19 Bn
5 Novartis Ag 315.40 Bn 288.64 Bn -
6 Astrazeneca 292.28 Bn 266.18 Bn 13.26 Bn
7 Amgen 250.93 Bn 202.58 Bn 7.58 Bn
8 Gilead Sciences 209.69 Bn 184.80 Bn 6.73 Bn
9 Pfizer 167.04 Bn 114.40 Bn 12.56 Bn
10 Kala Bio 2.59 Mn -42.05 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2022 409,000.00
Jun 30, 2022 326,000.00
Mar 31, 2022 597,000.00
Dec 31, 2021 438,000.00
Sep 30, 2021 2.16 Mn
Jun 30, 2021 2.04 Mn
Mar 31, 2021 2.51 Mn
Dec 31, 2020 879,000.00
Sep 30, 2020 1.52 Mn
Jun 30, 2020 74,000.00
Mar 31, 2020 717,000.00
Dec 31, 2019 433,000.00
Sep 30, 2019 783,000.00
Jun 30, 2019 1.71 Mn
Mar 31, 2019 1.15 Mn
API Access

Kala Bio Gross Profit API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gross-profit&ticker=KALA&period=max&api_key=YOUR_API_KEY